South San Francisco-based X-37 LLC, an artificial intelligence-enabled drug discovery company, has secured $14.5 million in Series A financing. DCVC Bio led the round with participation from Alpha Intelligence Capital and Hemi Ventures.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.